Jonathan Stuart Kaplan

Array ( [id] => 5613567 [patent_doc_number] => 20060115495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Protein-noble metal nanoparticles' [patent_app_type] => utility [patent_app_number] => 11/271392 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13465 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115495.pdf [firstpage_image] =>[orig_patent_app_number] => 11271392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802617 [patent_doc_number] => 20080014204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Compositions Against Sars-Coronavirus and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/667640 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29553 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014204.pdf [firstpage_image] =>[orig_patent_app_number] => 11667640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912348 [patent_doc_number] => 20060127410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Naturally processed measles virus peptides eluted from class II HLA molecules' [patent_app_type] => utility [patent_app_number] => 11/266957 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127410.pdf [firstpage_image] =>[orig_patent_app_number] => 11266957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873205 [patent_doc_number] => 20080199939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Adenoviral Vectors and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/665276 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18206 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199939.pdf [firstpage_image] =>[orig_patent_app_number] => 11665276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4439989 [patent_doc_number] => 07927601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof' [patent_app_type] => utility [patent_app_number] => 11/576249 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 14396 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927601.pdf [firstpage_image] =>[orig_patent_app_number] => 11576249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631481 [patent_doc_number] => 20060147950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Precursor conversion screening method' [patent_app_type] => utility [patent_app_number] => 11/223258 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6893 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147950.pdf [firstpage_image] =>[orig_patent_app_number] => 11223258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666612 [patent_doc_number] => 20060171962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'SARS vaccine' [patent_app_type] => utility [patent_app_number] => 11/217337 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7201 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171962.pdf [firstpage_image] =>[orig_patent_app_number] => 11217337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769589 [patent_doc_number] => 20060020110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Synthetic peptides that bind to the hepatitis B virus core and E antigens' [patent_app_type] => utility [patent_app_number] => 11/188187 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27088 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020110.pdf [firstpage_image] =>[orig_patent_app_number] => 11188187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7227864 [patent_doc_number] => 20050255461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E' [patent_app_type] => utility [patent_app_number] => 11/184574 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20476 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255461.pdf [firstpage_image] =>[orig_patent_app_number] => 11184574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880849 [patent_doc_number] => 20060029932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Method for preventing HIV-1 infection of CD4+ cells' [patent_app_type] => utility [patent_app_number] => 11/175815 [patent_app_country] => US [patent_app_date] => 2005-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9330 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029932.pdf [firstpage_image] =>[orig_patent_app_number] => 11175815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5687809 [patent_doc_number] => 20060286124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Vaccine compositions and methods of treating coronavirus infection' [patent_app_type] => utility [patent_app_number] => 11/173793 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35164 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286124.pdf [firstpage_image] =>[orig_patent_app_number] => 11173793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792062 [patent_doc_number] => 20080293036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Monoclonal Antibodies to Hiv-1 and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 11/630880 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12540 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293036.pdf [firstpage_image] =>[orig_patent_app_number] => 11630880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860265 [patent_doc_number] => 20080269115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Immunogenic Sars Domain' [patent_app_type] => utility [patent_app_number] => 11/570528 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7024 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269115.pdf [firstpage_image] =>[orig_patent_app_number] => 11570528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232378 [patent_doc_number] => 08197819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Env polypeptide complexes and methods of use' [patent_app_type] => utility [patent_app_number] => 11/597337 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 28137 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/197/08197819.pdf [firstpage_image] =>[orig_patent_app_number] => 11597337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270637 [patent_doc_number] => 07563873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/148012 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563873.pdf [firstpage_image] =>[orig_patent_app_number] => 11148012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80661 [patent_doc_number] => 07744887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Human antibodies interacting with HIV gp41' [patent_app_type] => utility [patent_app_number] => 11/628164 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28205 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744887.pdf [firstpage_image] =>[orig_patent_app_number] => 11628164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5601829 [patent_doc_number] => 20060292174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Self-assembling nanoparticle drug delivery system' [patent_app_type] => utility [patent_app_number] => 11/138593 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9312 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292174.pdf [firstpage_image] =>[orig_patent_app_number] => 11138593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770793 [patent_doc_number] => 20050266550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'TC-83-derived alphavirus vectors, particles and methods' [patent_app_type] => utility [patent_app_number] => 11/132711 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16449 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266550.pdf [firstpage_image] =>[orig_patent_app_number] => 11132711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019279 [patent_doc_number] => 20050221298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease' [patent_app_type] => utility [patent_app_number] => 11/131749 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12661 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221298.pdf [firstpage_image] =>[orig_patent_app_number] => 11131749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860691 [patent_doc_number] => 07371837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Human virus causing respiratory tract infection and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/129741 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 201 [patent_figures_cnt] => 17 [patent_no_of_words] => 28633 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371837.pdf [firstpage_image] =>[orig_patent_app_number] => 11129741 [rel_patent_id] =>[rel_patent_doc_number] =>)